{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:26:02Z","timestamp":1792697162058,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T00:00:00Z","timestamp":1574035200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T00:00:00Z","timestamp":1574035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s40257-019-00485-z","type":"journal-article","created":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T13:01:43Z","timestamp":1574082103000},"page":"163-172","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Drug-Induced Intracranial Hypertension: A Systematic Review and Critical Assessment of Drug-Induced Causes"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5718-7783","authenticated-orcid":false,"given":"Marcus G.","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Worley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whan B.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"ten Hove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Beecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,18]]},"reference":[{"key":"485_CR1","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1212\/WNL.0b013e3182a55f17","volume":"81","author":"DI Friedman","year":"2013","unstructured":"Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81:1159\u201365.","journal-title":"Neurology."},{"key":"485_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2165\/00128071-200506010-00004","volume":"6","author":"DI Friedman","year":"2005","unstructured":"Friedman DI. Medication-induced intracranial hypertension in dermatology. Am J Clin Dermatol. 2005;6:29\u201337.","journal-title":"Am J Clin Dermatol"},{"key":"485_CR3","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ijmedinf.2007.08.010","volume":"77","author":"Y Koh","year":"2008","unstructured":"Koh Y, Yap CW, Li SC. A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system. Int J Med Informatics. 2008;77:421\u201330.","journal-title":"Int J Med Informatics"},{"key":"485_CR4","doi-asserted-by":"crossref","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008\u201312.","DOI":"10.1001\/jama.283.15.2008"},{"key":"485_CR5","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/jb\/mvp142","volume":"146","author":"A Kushida","year":"2009","unstructured":"Kushida A, Tamura H. Retinoic acids induce neurosteroid biosynthesis in human glial GI-1 Cells via the induction of steroidogenic genes. J Biochem. 2009;146:917\u201323.","journal-title":"J Biochem"},{"key":"485_CR6","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/ana.10377","volume":"52","author":"JE Warner","year":"2002","unstructured":"Warner JE, Bernstein PS, Yemelyanov A, Alder SC, Farnsworth ST, Digre KB. Vitamin A in the cerebrospinal fluid of patients with and without idiopathic intracranial hypertension. Ann Neurol. 2002;52:647\u201350.","journal-title":"Ann Neurol"},{"key":"485_CR7","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1159\/000114758","volume":"14","author":"A Lombaert","year":"1976","unstructured":"Lombaert A, Carton H. Benign intracranial hypertension due to A-hypervitaminosis in adults and adolescents. Eur Neurol. 1976;14:340\u201350.","journal-title":"Eur Neurol"},{"key":"485_CR8","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1212\/WNL.34.11.1509","volume":"34","author":"RH Spector","year":"1984","unstructured":"Spector RH, Carlisle J. Pseudotumor cerebri caused by a synthetic vitamin A preparation. Neurology. 1984;34:1509\u201311.","journal-title":"Neurology."},{"key":"485_CR9","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.ophtha.2003.09.044","volume":"111","author":"FW Fraunfelder","year":"2004","unstructured":"Fraunfelder FW, Fraunfelder FT, Corbett JJ. Isotretinoin-associated intracranial hypertension. Ophthalmology. 2004;111:1248\u201350.","journal-title":"Ophthalmology"},{"key":"485_CR10","first-page":"165","volume":"55","author":"AG Lee","year":"1995","unstructured":"Lee AG. Pseudotumor cerebri after treatment with tetracycline and isotretinoin for acne. Cutis. 1995;55:165\u201373.","journal-title":"Cutis"},{"key":"485_CR11","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/0002-9394(85)90676-2","volume":"100","author":"FT Fraunfelder","year":"1985","unstructured":"Fraunfelder FT, LaBraico JM, Meyer SM. Adverse ocular reactions possibly associated with isotretinoin. Am J Ophthalmol. 1985;100:534\u20137.","journal-title":"Am J Ophthalmol"},{"key":"485_CR12","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1111\/bjd.14294","volume":"174","author":"DM Caruana","year":"2016","unstructured":"Caruana DM, Wylie G. \u2018Washout\u2019 period for oral tetracycline antibiotics prior to systemic isotretinoin. Br J Dermatol. 2016;174:929\u201330.","journal-title":"Br J Dermatol"},{"key":"485_CR13","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S0002-9394(98)00063-4","volume":"126","author":"AM Chiu","year":"1998","unstructured":"Chiu AM, Chuenkongkaew WL, Cornblath WT, Trobe JD, Digre KB, Dotan SA, et al. Minocycline treatment and pseudotumor cerebri syndrome. Am J Ophthalmol. 1998;126:116\u201321.","journal-title":"Am J Ophthalmol"},{"key":"485_CR14","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1001\/jamadermatol.2015.3447","volume":"152","author":"SJ Tintle","year":"2016","unstructured":"Tintle SJ, Harper JC, Webster GF, Kim GK, Thiboutot DM. Safe Use of Therapeutic-Dose Oral Isotretinoin in Patients With a History of Pseudotumor Cerebri. JAMA Dermatol. 2016;152:582\u20134.","journal-title":"JAMA Dermatol."},{"key":"485_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/01.chi.0000150616.95987.7e","volume":"44","author":"J Jonnalagadda","year":"2005","unstructured":"Jonnalagadda J, Saito E, Kafantaris V. Lithium, minocycline, and pseudotumor cerebri. J Am Acad Child Adolesc Psychiatry. 2005;44:209.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"485_CR16","first-page":"34","volume":"173","author":"D Caruana","year":"2015","unstructured":"Caruana D, Wylie G. \u201cWash-out\u201d period for oral tetracycline antibiotics prior to systemic isotretinoin. Br J Dermatol. 2015;173:34\u20135.","journal-title":"Br J Dermatol"},{"key":"485_CR17","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1684\/ejd.2011.1545","volume":"21","author":"V Bettoli","year":"2011","unstructured":"Bettoli V, Borghi A, Mantovani L, Scorrano R, Minghetti S, Toni G, et al. Safe use of oral isotretinoin after pseudotumor cerebri due to minocycline. Eur J Dermatol. 2011;21:1024\u20135.","journal-title":"Eur J Dermatol."},{"key":"485_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/WNO.0000000000000301","volume":"36","author":"C Law","year":"2016","unstructured":"Law C, Yau GL, ten Hove M. Delayed development of intracranial hypertension after discontinuation of tetracycline treatment for acne vulgaris. J Neuroophthalmol. 2016;36:67\u20139.","journal-title":"J Neuroophthalmol"},{"key":"485_CR19","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1212\/WNL.62.12.2297","volume":"62","author":"DI Friedman","year":"2004","unstructured":"Friedman DI, Gordon LK, Egan RA, Jacobson DM, Pomeranz H, Harrison AR, et al. Doxycycline and intracranial hypertension. Neurology. 2004;62:2297\u20139.","journal-title":"Neurology."},{"key":"485_CR20","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1177\/088307380101600617","volume":"16","author":"A Levine","year":"2001","unstructured":"Levine A, Watemberg N, Hager H, Bujanover Y, Ballin A, Lerman-Sagie T. Benign intracranial hypertension associated with budesonide treatment in children with Crohn\u2019s disease. J Child Neurol. 2001;16:458\u201361.","journal-title":"J Child Neurol"},{"key":"485_CR21","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1097\/01.mcg.0000139032.53816.68","volume":"38","author":"JM Chebli","year":"2004","unstructured":"Chebli JM, Gaburri PD, de Souza AF, da Silva CE, Pinto JR, Felga GE. Benign intracranial hypertension during corticosteroid therapy for idiopathic ulcerative colitis: another indication for cyclosporine? J Clin Gastroenterol. 2004;38:827\u20138.","journal-title":"J Clin Gastroenterol"},{"key":"485_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nbt.2113","volume":"30","author":"R Bohm","year":"2012","unstructured":"Bohm R, Hocker J, Cascorbi I, Herdegen T. OpenVigil-free eyeballs on AERS pharmacovigilance data. Nat Biotechnol. 2012;30:137\u20138.","journal-title":"Nat Biotechnol"},{"key":"485_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/2042098615621264","volume":"7","author":"M Etminan","year":"2016","unstructured":"Etminan M. Risk of intracranial hypertension with intrauterine levonorgestrel: reply. Ther Adv Drug Saf. 2016;7:25\u20136.","journal-title":"Ther Adv Drug Saf."},{"key":"485_CR24","first-page":"2228","volume":"56","author":"R Rai","year":"2015","unstructured":"Rai R, Kirk B, Sanders J, Valenzuela R, Sundar S, Warner J, et al. The relationship between the levonorgestrel-releasing intrauterine system and idiopathic intracranial hypertension. Invest Ophthalmol Vis Sci. 2015;56:2228.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"485_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/WNO.0000000000000073","volume":"34","author":"JC Koerner","year":"2014","unstructured":"Koerner JC, Friedman DI. Inpatient and emergency service utilization in patients with idiopathic intracranial hypertension. J Neuroophthalmol. 2014;34:229\u201332.","journal-title":"J Neuroophthalmol"},{"key":"485_CR26","doi-asserted-by":"crossref","unstructured":"Ireland B, Corbett JJ, Wallace RB. The search for causes of idiopathic intracranial hypertension. A preliminary case-control study. Arch Neurol. 1990;47:315\u201320.","DOI":"10.1001\/archneur.1990.00530030091021"},{"key":"485_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1212\/WNL.41.2_Part_1.239","volume":"41","author":"V Giuseffi","year":"1991","unstructured":"Giuseffi V, Wall M, Siegel PZ, Rojas PB. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology. 1991;41:239\u201344.","journal-title":"Neurology."},{"key":"485_CR28","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.ncl.2010.03.003","volume":"28","author":"M Wall","year":"2010","unstructured":"Wall M. Idiopathic Intracranial Hypertension. Neurol Clin. 2010;28:593\u2013617.","journal-title":"Neurol Clin"},{"key":"485_CR29","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1177\/112067210701700430","volume":"17","author":"AR Reddy","year":"2007","unstructured":"Reddy AR, Backhouse OC. Contraceptive, cerebral vein thrombosis and choked discs. Eur J Ophthalmol. 2007;17:669\u201370.","journal-title":"Eur J Ophthalmol"},{"key":"485_CR30","doi-asserted-by":"crossref","unstructured":"Ahmed H, Ali H. Risperidone induced weight gain leading to benign intracranial hypertension. BMJ Case Rep. 2011;2011.","DOI":"10.1136\/bcr.06.2011.4320"},{"key":"485_CR31","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1067\/S0022-3476(03)00291-9","volume":"143","author":"DE Neely","year":"2003","unstructured":"Neely DE, Plager DA, Kumar N. Desmopressin (DDAVP)-induced pseudotumor cerebri. J Pediatr. 2003;143:808.","journal-title":"J Pediatr"},{"key":"485_CR32","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1080\/14737175.2019.1660163","volume":"19","author":"DI Friedman","year":"2019","unstructured":"Friedman DI. Contemporary management of the pseudotumor cerebri syndrome. Expert Rev Neurother. 2019;19:881\u201393.","journal-title":"Expert Rev Neurother"},{"key":"485_CR33","doi-asserted-by":"crossref","unstructured":"NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee, Wall M, McDermott MP, Kieburtz KD, Corbett JJ, Feldon SE, et al. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA. 2014;311:1641\u201351.","DOI":"10.1001\/jama.2014.3312"},{"key":"485_CR34","doi-asserted-by":"crossref","unstructured":"Smith SV, Friedman DI. The idiopathic intracranial hypertension treatment trial: a review of the outcomes. Headache. 2017;57:1303\u201310.","DOI":"10.1111\/head.13144"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-019-00485-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-019-00485-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-019-00485-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:44:32Z","timestamp":1605573872000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-019-00485-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,18]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["485"],"URL":"https:\/\/doi.org\/10.1007\/s40257-019-00485-z","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,18]]},"assertion":[{"value":"18 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No funding was provided in support of the research completed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors, Marcus G. Tan, Brandon Worley, Whan B. Kim, Martin ten Hove, and Jennifer Beecker have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}